223 related articles for article (PubMed ID: 21209961)
21. EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia.
Anderson SL; Qiu J; Rubin BY
Biochem Biophys Res Commun; 2003 Oct; 310(2):627-33. PubMed ID: 14521957
[TBL] [Abstract][Full Text] [Related]
22. IKAP deficiency in an FD mouse model and in oligodendrocyte precursor cells results in downregulation of genes involved in oligodendrocyte differentiation and myelin formation.
Cheishvili D; Dietrich P; Maayan C; Even A; Weil M; Dragatsis I; Razin A
PLoS One; 2014; 9(4):e94612. PubMed ID: 24760006
[TBL] [Abstract][Full Text] [Related]
23. Nutraceutical-mediated restoration of wild-type levels of IKBKAP-encoded IKAP protein in familial dysautonomia-derived cells.
Anderson SL; Liu B; Qiu J; Sturm AJ; Schwartz JA; Peters AJ; Sullivan KA; Rubin BY
Mol Nutr Food Res; 2012 Apr; 56(4):570-9. PubMed ID: 22495984
[TBL] [Abstract][Full Text] [Related]
24. Effects of IKAP/hELP1 deficiency on gene expression in differentiating neuroblastoma cells: implications for familial dysautonomia.
Cohen-Kupiec R; Pasmanik-Chor M; Oron-Karni V; Weil M
PLoS One; 2011 Apr; 6(4):e19147. PubMed ID: 21559466
[TBL] [Abstract][Full Text] [Related]
25. IKBKAP mRNA in peripheral blood leukocytes: a molecular marker of gene expression and splicing in familial dysautonomia.
Gold-von Simson G; Leyne M; Mull J; Rolnitzky LM; Goldberg JD; Berlin D; Axelrod FB; Slaugenhaupt SA
Pediatr Res; 2008 Feb; 63(2):186-90. PubMed ID: 18091349
[TBL] [Abstract][Full Text] [Related]
26. Deletion of exon 20 of the Familial Dysautonomia gene Ikbkap in mice causes developmental delay, cardiovascular defects, and early embryonic lethality.
Dietrich P; Yue J; E S; Dragatsis I
PLoS One; 2011; 6(10):e27015. PubMed ID: 22046433
[TBL] [Abstract][Full Text] [Related]
27. Dynamic changes in IKBKAP mRNA levels during crisis of familial dysautonomia patients.
Cheishvili D; Laiba E; Rekhtman D; Claman A; Razin A; Maayan C
Auton Neurosci; 2014 Feb; 180():59-65. PubMed ID: 24268683
[TBL] [Abstract][Full Text] [Related]
28. [Molecular and cellular characterization ion of IKAP protein and the Elongator complex. Implications for familial dysautonomia].
Close P; Creppe C; Cornez I; Chariot A
Bull Mem Acad R Med Belg; 2007; 162(5-6):315-22. PubMed ID: 18405001
[TBL] [Abstract][Full Text] [Related]
29. ELP1 Splicing Correction Reverses Proprioceptive Sensory Loss in Familial Dysautonomia.
Morini E; Gao D; Montgomery CM; Salani M; Mazzasette C; Krussig TA; Swain B; Dietrich P; Narasimhan J; Gabbeta V; Dakka A; Hedrick J; Zhao X; Weetall M; Naryshkin NA; Wojtkiewicz GG; Ko CP; Talkowski ME; Dragatsis I; Slaugenhaupt SA
Am J Hum Genet; 2019 Apr; 104(4):638-650. PubMed ID: 30905397
[TBL] [Abstract][Full Text] [Related]
30. Loss of
Ueki Y; Ramirez G; Salcedo E; Stabio ME; Lefcort F
eNeuro; 2016; 3(5):. PubMed ID: 27699209
[TBL] [Abstract][Full Text] [Related]
31. IKAP/hELP1 deficiency in the cerebrum of familial dysautonomia patients results in down regulation of genes involved in oligodendrocyte differentiation and in myelination.
Cheishvili D; Maayan C; Smith Y; Ast G; Razin A
Hum Mol Genet; 2007 Sep; 16(17):2097-104. PubMed ID: 17591626
[TBL] [Abstract][Full Text] [Related]
32. A humanized IKBKAP transgenic mouse models a tissue-specific human splicing defect.
Hims MM; Shetty RS; Pickel J; Mull J; Leyne M; Liu L; Gusella JF; Slaugenhaupt SA
Genomics; 2007 Sep; 90(3):389-96. PubMed ID: 17644305
[TBL] [Abstract][Full Text] [Related]
33. Familial dysautonomia is caused by mutations of the IKAP gene.
Anderson SL; Coli R; Daly IW; Kichula EA; Rork MJ; Volpi SA; Ekstein J; Rubin BY
Am J Hum Genet; 2001 Mar; 68(3):753-8. PubMed ID: 11179021
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide analysis of familial dysautonomia and kinetin target genes with patient olfactory ecto-mesenchymal stem cells.
Boone N; Bergon A; Loriod B; Devèze A; Nguyen C; Axelrod FB; Ibrahim EC
Hum Mutat; 2012 Mar; 33(3):530-40. PubMed ID: 22190446
[TBL] [Abstract][Full Text] [Related]
35. Tocotrienols reverse IKAP and monoamine oxidase deficiencies in familial dysautonomia.
Anderson SL; Rubin BY
Biochem Biophys Res Commun; 2005 Oct; 336(1):150-6. PubMed ID: 16125677
[TBL] [Abstract][Full Text] [Related]
36. Familial dysautonomia.
Slaugenhaupt SA; Gusella JF
Curr Opin Genet Dev; 2002 Jun; 12(3):307-11. PubMed ID: 12076674
[TBL] [Abstract][Full Text] [Related]
37. IKAP/Elp1 involvement in cytoskeleton regulation and implication for familial dysautonomia.
Cheishvili D; Maayan C; Cohen-Kupiec R; Lefler S; Weil M; Ast G; Razin A
Hum Mol Genet; 2011 Apr; 20(8):1585-94. PubMed ID: 21273291
[TBL] [Abstract][Full Text] [Related]
38. Genomic organization and chromosomal localization of the mouse IKBKAP gene.
Coli R; Anderson SL; Volpi SA; Rubin BY
Gene; 2001 Nov; 279(1):81-9. PubMed ID: 11722848
[TBL] [Abstract][Full Text] [Related]
39. Cardiac glycosides correct aberrant splicing of IKBKAP-encoded mRNA in familial dysautonomia derived cells by suppressing expression of SRSF3.
Liu B; Anderson SL; Qiu J; Rubin BY
FEBS J; 2013 Aug; 280(15):3632-46. PubMed ID: 23711097
[TBL] [Abstract][Full Text] [Related]
40. Induced pluripotent stem cell (iPSC) lines from two individuals carrying a homozygous (BGUi007-A) and a heterozygous (BGUi006-A) mutation in ELP1 for in vitro modeling of familial dysautonomia.
Dor L; Rabinski T; Zlotnik D; Shilian M; Weil M; Vatine GD
Stem Cell Res; 2021 Aug; 55():102495. PubMed ID: 34419746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
